This correction reports on predictors of inflammatory arthritis from immune checkpoint inhibitors related to hip osteoarthritis.
J Rheumatol 2026; doi: 10.3899/jrheum.2025-0808 In the originally published online version of this article, reference 8 was missing from the list of references. The missing reference has now been added: "8. Cunningham-Bussel A, Wang J, Prisco LC, et al. Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer. Arthritis Rheumatol 2022;74:527-40." This correction applies only to the February 1 2026 First Release. The complete list of references appears in the print and online issues.
No takes yet. Share an insight, caveat, or question.
Fitzpatrick et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: